{"protocolSection":{"identificationModule":{"nctId":"NCT01028794","orgStudyIdInfo":{"id":"UMIN000001133"},"secondaryIdInfos":[{"id":"UMIN000001133","type":"OTHER","domain":"University hospital Medical Information Network in Japan"}],"organization":{"fullName":"National Cerebral and Cardiovascular Center, Japan","class":"OTHER"},"briefTitle":"Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients","officialTitle":"Phase 1/2A Study of Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Patients After Cerebral Embolism"},"statusModule":{"statusVerifiedDate":"2013-07","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2008-05"},"primaryCompletionDateStruct":{"date":"2013-07","type":"ACTUAL"},"completionDateStruct":{"date":"2013-07","type":"ACTUAL"},"studyFirstSubmitDate":"2009-12-08","studyFirstSubmitQcDate":"2009-12-08","studyFirstPostDateStruct":{"date":"2009-12-09","type":"ESTIMATED"},"lastUpdateSubmitDate":"2013-07-04","lastUpdatePostDateStruct":{"date":"2013-07-08","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Akihiko Taguchi","investigatorTitle":"guest investigator","investigatorAffiliation":"National Cerebral and Cardiovascular Center, Japan"},"leadSponsor":{"name":"National Cerebral and Cardiovascular Center, Japan","class":"OTHER"},"collaborators":[{"name":"Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether autologous bone marrow mononuclear cells transplantation after stroke is safe and/or effective to improve neurological outcome."},"conditionsModule":{"conditions":["Cerebral Embolism","Stroke"],"keywords":["stroke","bone marrow","mononuclear cell","angiogenesis","neurogenesis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1","PHASE2"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":12,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"autologous bone marrow mononuclear cell","type":"EXPERIMENTAL","description":"On day 7-10 after stroke, patient has 25ml of bone marrow cells aspiration. Mononuclear cells are purified by Ficoll and administrated intravenously.","interventionNames":["Biological: autologous bone marrow mononuclear cells"]},{"label":"autologous bone marrow mononuclear cells","type":"EXPERIMENTAL","description":"On day 7-10 after stroke, patient has 50ml of bone marrow cells aspiration. Mononuclear cells are purified by Ficoll and administrated intravenously.","interventionNames":["Biological: autologous bone marrow mononuclear cells"]}],"interventions":[{"type":"BIOLOGICAL","name":"autologous bone marrow mononuclear cells","description":"intravenous administration of autologous bone marrow derived mononuclear cells obtained from 25ml of bone marrow on day 7-10 after stroke (only once in that period)","armGroupLabels":["autologous bone marrow mononuclear cell"]},{"type":"BIOLOGICAL","name":"autologous bone marrow mononuclear cells","description":"intravenous administration of autologous bone marrow derived mononuclear cells obtained from 50ml of bone marrow on day 7-10 after stroke (only once in that period)","armGroupLabels":["autologous bone marrow mononuclear cells"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Improvement of NIHSS（National Institute of Health Stroke Scale）","timeFrame":"30 days after treatment"},{"measure":"Frequency of change for the worse in NIHSS","timeFrame":"30 days aftrer treatment"}],"secondaryOutcomes":[{"measure":"Mean level of mRS (modified Rankin Scale)","timeFrame":"30 days after treatment"},{"measure":"Frequency of death","timeFrame":"day 30 after treatment"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with cerebral embolism.\n* NIHSS score is more than (or equal to) 10.\n* On day 7 after onset of stroke, the improvement of NIHSS is less than (or equal to) 5, compared with the level at administration.\n* Bone marrow aspiration can be done in 10 days after onset of stroke\n\nExclusion Criteria:\n\n* Patient with cerebral hemorrhage or symptomatic hemorrhagic infarction.\n* Patient who expects brain surgery.\n* Patient with acute myocardial infarction.\n* Patient with coagulation disorder.\n* Number of Platelet \\< 100000/mm3\n* Serum creatinine level \\>2.0mg/dl\n* Patient with malignancy.\n* Patient with uncontrolled proliferative diabetic retinopathy.\n* Patient suspected infective endocarditis.\n* HBV, HCV, HIV or HTLV positive","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Akihiko Taguchi, MD.PhD","affiliation":"Department of Cerebrovascular Disease, National Cardiovascular Center","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Department of Cerebrovascular Disease, National Cardiovascular Center","city":"Suita","state":"Osaka","zip":"565-8565","country":"Japan","geoPoint":{"lat":34.76143,"lon":135.51567}}]},"referencesModule":{"references":[{"pmid":"15286799","type":"BACKGROUND","citation":"Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H, Matsuyama T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004 Aug;114(3):330-8. doi: 10.1172/JCI20622."},{"pmid":"12623341","type":"BACKGROUND","citation":"Taguchi A, Ohtani M, Soma T, Watanabe M, Kinosita N. Therapeutic angiogenesis by autologous bone-marrow transplantation in a general hospital setting. Eur J Vasc Endovasc Surg. 2003 Mar;25(3):276-8. doi: 10.1053/ejvs.2002.1831. No abstract available."},{"pmid":"15184275","type":"BACKGROUND","citation":"Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, Todo K, Mori K, Stern DM, Soma T, Naritomi H. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation. 2004 Jun 22;109(24):2972-5. doi: 10.1161/01.CIR.0000133311.25587.DE. Epub 2004 Jun 7."},{"pmid":"17614944","type":"BACKGROUND","citation":"Taguchi A, Wen Z, Myojin K, Yoshihara T, Nakagomi T, Nakayama D, Tanaka H, Soma T, Stern DM, Naritomi H, Matsuyama T. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur J Neurosci. 2007 Jul;26(1):126-33. doi: 10.1111/j.1460-9568.2007.05640.x."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000020766","term":"Intracranial Embolism"},{"id":"D000004617","term":"Embolism"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000016769","term":"Embolism and Thrombosis"},{"id":"D000002542","term":"Intracranial Embolism and Thrombosis"},{"id":"D000013923","term":"Thromboembolism"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M7474","name":"Embolism","asFound":"Embolism","relevance":"HIGH"},{"id":"M22212","name":"Intracranial Embolism","asFound":"Cerebral Embolism","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M16376","name":"Thrombosis","relevance":"LOW"},{"id":"M18818","name":"Embolism and Thrombosis","relevance":"LOW"},{"id":"M5481","name":"Intracranial Embolism and Thrombosis","relevance":"LOW"},{"id":"M16372","name":"Thromboembolism","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}